The Patent Finder

Kindex Therapeutics, LLC

Also on record
Records under this name other than patents Kindex Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Kindex Therapeutics, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,410,178CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Formerly held
Lapsed on the fee record
Ended Apr 2, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 2, 2025USPTO record
US 8,410,179Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Formerly held
Lapsed on the fee record
Ended Apr 2, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 2, 2025USPTO record
US 8,829,056Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
Formerly held
Lapsed on the fee record
Ended Sep 9, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 9, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited